Brought to you by the International Journal of Pharmaceutical Compounding FREE TRIAL    FORMULATIONS    MY ACCOUNT 
Compounding This Week Newsletter from
Our Compounding Knowledge, Your Peace of Mind
January 19, 2018  |  Volume 15  |  Issue 3
IJPC: Our Compounding Knowledge - Your Peace of Mind!
Medisca's New Powerful Promill - For the High Volume Compounder.
Loyd V. Allen, Jr., Ph.d., R.Ph Letter from the Editor
New Look for IJPC

Do you enjoy remodeling, upgrading, refreshing your home or office? Well, the International Journal of Pharmaceutical Compounding (IJPC) is now changing the cover design of our journal, beginning with the January/February 2018 issue.

IJPC presents a fresh, new look with this issue (January/February 2018). The change includes the new IJPC logo and a new masthead. The centerpiece of all the covers will remain the same—the mortar and pestle. The content will continue to evolve with the changing landscape of pharmaceutical compounding. As the only pharmacy journal dedicated solely to compounding, we continue to support quality pharmaceutical compounding, worldwide. A comparison of the old and the new is shown below:

New vs Old IJPC Covers

Loyd V. Allen, Jr., PhD, RPh
International Journal of Pharmaceutical Compounding
Remington: The Science and Practice of Pharmacy Twenty-second edition



The FDA has just released their 2018 Compounding Policy Priorities Plan available at:

This newsletter will look at this in detail over the next few issues.



New York Looks at Drug Take-back Programs
New York state senators have filed the "Drug Take Back Act," which instead of being aimed directly at drugmakers, would require chain and mail-order pharmacies to establish federally approved disposal systems for consumers. This might include on-site disposal or prepaid mail-back envelopes. One of the bill's sponsors said that since some drug addictions start with leftover meds, "cutting off that supply is essential."

EMA Bans Antibiotic APIs Produced by the Drugmaker in Mongolia
European authorities have blocked the amoxicillin trihydrate active pharmaceutical ingredient (API) which is produced by a company in China, whose manufacturing quality oversight has been found to be weak. This involves Inner Mongolia Changsheng Pharmaceutical and follows an October inspection of its plant in Tuoketuo, Hohhot, Inner Mongolia in China, by Belgium inspectors. Inspectors listed one critical and eight major deficiencies. The critical deficiency was tied to the quality-assurance system, which inspectors reported was incapable of establishing acceptable standards across the whole spectrum of processes. They specifically noted oversight of deviations, quality control, validation, complaint management, documentation, among others. Both U.S. and European authorities have stepped up oversight of Chinese companies as more are found shipping ingredients to the West.


Did You Know ...

…about the Top 10 Myths of Taste Masking? Here are a few of them.

  1. Taste and aroma are the same.
  2. Only APIs require taste masking.
  3. The most intense sweetener is the best sweetener.
  4. Solids and suspensions don't require taste masking


Tip of the Week

To learn about all the ten myths, go to the following website for free information available as a download:


IJPC Now on Facebook and Youtube

Become a fan of the IJPC Facebook page and share ideas, photos, and keep up to date with the latest compounding information -

View our growing collection of educational and training videos at or by subscribing to our Youtube channel at


Looking Back

Forest fires,
Start from scratch,
So think before,
You toss that match!
     Burma Shave

Copyright 2018
International Journal of Pharmaceutical Compounding, Inc.
122 N Bryant Ave, Edmond OK 73034
Manage my Email:
Subscribe / Un-Subscribe
Comments or Questions:
Reprints & Permissions: